Shuttle Pharmaceuticals（SHPH.US）股东结构 - 机构持仓、大股东与内部人士｜长桥证券

© 2026 Longbridge｜服务条款隐私政策

股东类型

公众及其他94.19%
机构投资者5.34%
个人与内部人士0.47%

主要股东

主要股东最新
股东
Citadel Advisors LLC	4.16%	2.44 万	--	+2.44 万	2026/06/30
Armistice Capital LLC	0.96%	5,624.00	0.05%	+0	2025/06/30
Anatoly DritschiloCo-Founder, Former Co-CEO & Chairman of the Board	0.37%	2,145.00	0.02%	+0	2025/03/13
Barclays Bank Plc	0.13%	750.00	--	+750.00	2026/06/30
Mira JungCo-Founder & Chief Scientific Officer for Biology	0.09%	543.00	<0.01%	+0	2025/03/13
Tower Research Capital Europe Limited	0.07%	389.00	0.02%	-75.00	2026/06/30
Kelleher Financial Advisors, LLC	0.02%	120.00	<0.01%	+60.00	2026/06/30
Michael Vander HoekVice President for Operations and Regulatory	<0.01%	52.00	<0.01%	+0	2025/03/13
FMR LLC	<0.01%	26.00	<0.01%	+0	2026/05/31
Peter DritschiloFormer President, COO & Secretary	<0.01%	3.00	<0.01%	+0	2025/03/13
Tyvin RichChief Clinical Officer & Chief Medical Officer	<0.01%	1.00	<0.01%	+0	2025/03/13
Steven RichardsFormer Independent Director	<0.01%	1.00	<0.01%	+0	2025/03/13
Virtu Financial, Inc.	0.00%	0.00	0.22%	-1,238.00	2026/06/30
Geode Capital Management, LLC	0.00%	0.00	0.83%	-4,621.00	2026/06/30
UBS Asset Management AG	0.00%	0.00	0.10%	-567.00	2026/06/30
Boothbay Fund Management, LLC	0.00%	0.00	0.37%	-2,036.00	2026/06/30
Hudson River Trading LLC	0.00%	0.00	13.43%	-7.86 万	2026/07/14
Morgan Stanley	0.00%	0.00	<0.01%	-2.00	2026/06/30
Ikarian Capital, LLC	0.00%	0.00	1.24%	-6,899.00	2026/06/30